Risk Factors of Recurrent Anal Abscess in Patients with Type 2 Diabetes Mellitus; a 4-Year Retrospective study
Archives of Academic Emergency Medicine,
Vol. 10 No. 1 (2022),
1 January 2022
,
Page e69
https://doi.org/10.22037/aaem.v10i1.1692
Abstract
Introduction: Anal abscess is considered as a relatively common compilation in type 2 diabetes mellitus (T2DM) patients. This study aimed to determine the risk factors of recurrent anal abscess in T2DM patients.
Methods: In this 4-year retrospective cross-sectional study, T2DM patients hospitalized due to anal abscess in Shahid Modarres Hospital, Tehran, Iran from December 2016 to December 2020 were studied. The independent risk factors of disease recurrence were determined among demographic factors, underlying diseases, diabetes-related factors, clinical factors, laboratory parameters, abscess type, and culture using multivariate stepwise logistic regression analysis.
Results: 203 patients were enrolled in the study. 58 (28.6%) patients had at least one re-occurrence of anal abscess during four years. The recurrent episodes had occurred more frequently in the first year after the initial treatment (55.2%). The prevalence of comorbidities such as metabolic syndrome, coronary artery disease, chronic kidney disease, end stage renal disease, and peripheral vascular disease was significantly higher amongst patients with abscess recurrence. The patients with recurrent anal abscess had statically significant poor glycemic control (HbA1C > 7.5), decreased levels of Estimated Glomerular Filtration Rate (e-GFR), and higher C-reactive Protein (CRP) upon the first admission. Presence of metabolic syndrome, HbA1c > 7.5%, WBC > 11.0 ×109/L, and CRP > 5 mg/l were amongst the independent risk factors of recurrence. HbA1c > 7.5% was the greatest independent risk factor of anal abscess recurrence (OR=2.68, 95% CI: 1.37-5.25; p < 0.001). The area under the receiver operating characteristic (ROC) curve (AUC) of HbA1C, CRP, and WBC in predicting the risk of abscess recurrence was 0.81, 0.71, and 0.64, respectively.
Conclusion: Th recurrence rate of anal abscess in this series was 28.6 %. It seems that in T2DM patients with uncontrolled diabetes who have metabolic syndrome and increased CRP and WBC in their routine tests, the probability of anal abscess reoccurrence is high.
- diabetes mellitus
- abscess
- metabolic syndrome
- leukocytosis
- diabetes complications
How to Cite
References
Sneider EB, Maykel JA. Anal abscess and fistula. Gastroenterol Clin North Am. 2013;42(4):773-84.
Sigmon DF, Emmanuel B, Tuma F. Perianal Abscess. StatPearls. Treasure Island (FL): StatPearls Publishing LLC.; 2021.
Chernyadyev SA, Ufimtseva MA, Vishnevskaya IF, Bochkarev YM, Ushakov AA, Beresneva TA, et al. Fournier's Gangrene: Literature Review and Clinical Cases. Urol Int. 2018;101(1):91-7.
Kovalcik PJ, Peniston RL, Cross GH. Anorectal abscess. Surg Gynecol Obstet. 1979;149(6):884-6.
Adamo K, Gunnarsson U, Eeg-Olofsson K, Strigård K, Brännström F. Risk for developing perianal abscess in type 1 and type 2 diabetes and the impact of poor glycemic control. Int J Colorectal Dis. 2021;36(5):999-1005.
Adamo K, Sandblom G, Brännström F, Strigård K. Prevalence and recurrence rate of perianal abscess--a population-based study, Sweden 1997-2009. Int J Colorectal Dis. 2016;31(3):669-73.
Akkapulu N, Dere Ö, Zaim G, Soy HE, Özmen T, Doğrul AB. A retrospective analysis of 93 cases with anorectal abscess in a rural state hospital. Ulus Cerrahi Derg. 2015;31(1):5-8.
Devaraj B, Khabassi S, Cosman BC. Recent smoking is a risk factor for anal abscess and fistula. Dis Colon Rectum. 2011;54(6):681-5.
Almeida MSC, Sousa Filho LF, Rabello PM, Santiago BM. International Classification of Diseases - 11th revision: from design to implementation. Rev Saude Publica. 2020;54:104.
Wei PL, Keller JJ, Kuo LJ, Lin HC. Increased risk of diabetes following perianal abscess: a population-based follow-up study. Int J Colorectal Dis. 2013;28(2):235-40.
Xiang J, Wang S, He Y, Xu L, Zhang S, Tang Z. Reasonable Glycemic Control Would Help Wound Healing During the Treatment of Diabetic Foot Ulcers. Diabetes Ther. 2019;10(1):95-105.
Dudukgian H, Abcarian H. Why do we have so much trouble treating anal fistula? World J Gastroenterol. 2011;17(28):3292-6.
Silvestre J, Rebanda J, Lourenço C, Póvoa P. Diagnostic accuracy of C-reactive protein and procalcitonin in the early detection of infection after elective colorectal surgery - a pilot study. BMC Infect Dis. 2014;14:444.
Kwak MS, Kim KJ, Park SH, Yang DH, Ye BD, Byeon JS, et al. Elevated C-reactive protein is associated with disease progression in patients with mild Crohn's disease. Springerplus. 2016;5(1):878.
Hsieh MH, Lu YA, Kuo G, Chen CY, Sun WC, Lin Y, et al. Epidemiology and outcomes of anal abscess in patients on chronic dialysis: a 14-year retrospective study. Clinics (Sao Paulo). 2019;74:e638.
Liu CK, Liu CP, Leung CH, Sun FJ. Clinical and microbiological analysis of adult perianal abscess. J Microbiol Immunol Infect. 2011;44(3):204-8.
Berbudi A, Rahmadika N, Tjahjadi AI, Ruslami R. Type 2 Diabetes and its Impact on the Immune System. Curr Diabetes Rev. 2020;16(5):442-9.
Graves DT, Kayal RA. Diabetic complications and dysregulated innate immunity. Front Biosci. 2008;13:1227-39.
Sözener U, Gedik E, Kessaf Aslar A, Ergun H, Halil Elhan A, Memikoğlu O, et al. Does adjuvant antibiotic treatment after drainage of anorectal abscess prevent development of anal fistulas? A randomized, placebo-controlled, double-blind, multicenter study. Dis Colon Rectum. 2011;54(8):923-9.
- Abstract Viewed: 983 times
- pdf Downloaded: 565 times
Download Statastics
Make a Submission
SJR
COPE
